Rethinking Prognosis Through Pathology: How AI Is Revealing New Clues in Kidney Cancer
In this episode of MedInsights Unleashed, Hannah Timm, a researcher at the Institute for Artificial Intelligence in Medicine in Essen, Germany, who
Every conversation in one place — oncology and specialty medicine, translated into something you can act on.
In this episode of MedInsights Unleashed, Hannah Timm, a researcher at the Institute for Artificial Intelligence in Medicine in Essen, Germany, who

In this episode of MedInsights Unleashed, Dr. Richard S. Finn, MD, Professor of Medicine in the Division of Hematology/Oncology at the David

In this episode of MedInsights Unleashed, Dr. Ari Rosenberg, MD, Assistant Professor of Medicine at the University of Chicago Medical Center, returns

Can the communities we build become part of the healthcare system? In this episode of MedInsights Unleashed, Pascal Mittermaier explores how the

Cancer rehabilitation is changing the way we think about cancer care. Rather than waiting until treatment has ended or function has been

Breast cancer care continues to evolve rapidly as new research helps clinicians personalize treatment and improve patient outcomes. In this episode of

Many patients believe that once a prescription is written, receiving treatment is a straightforward process. In reality, prior authorizations, insurance requirements, specialty

The RASolute 302 trial represents a breakthrough in pancreatic cancer treatment, successfully doubling patient survival compared with standard care. In this episode

In this episode of MedInsights Unleashed, John Collins speaks with Professor Gregory Randolph MD, FACS, FACE, Bertucci Chair in Thyroid Surgical Oncology
